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Association of SBPand BMIwith cognitive and
structural brain phenotypes in UKBiobank
Amy C. Fergusona, Rachana Tanka, Laura M. Lyalla, Joey Warda, Paul Welshb
Carlos Celis-Moralesb, Ross McQueeniea, Rona J. Strawbridgea,c,d, Daniel F. Mackaya, Jill P. Pella,
Daniel J. Smitha, Naveed Sattarb, Jonathan Cavanagha, and Donald M. Lyalla
Objective: To test for associations between SBP and BMI,
with domain-specific cognitive abilities and examine which
brain structural phenotypes mediate those associations.
Methods: Using cross-sectional UK Biobank data (final
N¼28 412), we examined SBP/BMI vs. cognitive test scores
of pairs-matching, matrix completion, trail making test A/B,
digit symbol substitution, verbal–numerical reasoning,
tower rearranging and simple reaction time. We adjusted
for potential confounders of age, sex, deprivation,
medication, apolipoprotein e4 genotype, smoking,
population stratification and genotypic array. We tested for
mediation via multiple structural brain imaging phenotypes
and corrected for multiple testing with false discovery rate.
Results: We found positive associations for higher BMI
with worse reaction time, reasoning, tower rearranging
and matrix completion tasks by 0.024–0.067 SDs per BMI
SD (all P< 0.001). Higher SBP was associated with worse
reasoning (0.034 SDs) and matrix completion scores
(0.024 SDs; both P< 0.001). Both BMI and SBP were
associated with multiple brain structural metrics including
total grey/white matter volumes, frontal lobe volumes,
white matter tract integrity and white matter
hyperintensity volumes: specific metrics mediated around
one-third of the associations with cognition.
Conclusion: Our findings add to the body of evidence
that addressing cardiovascular risk factors may also
preserve cognitive function, via specific aspects of brain
structure.
Keywords: brain, cardiovascular, cognitive, epidemiology,
mediation
Abbreviations: APOE, apolipoprotein e; gFA, general
factor of fractional anisotropy; gMD, general factor of
mean diffusivity; SNP, single nucleotide polymorphism;
TMT, trail making test; WMH, white matter
hyperintensities
INTRODUCTION
P
oor cardiovascular health is a risk factor for worse
cognitive and structural brain health, including
dementia and stroke, potentially due to common
pathologies such as atherosclerosis [1]. Better
understanding these links could have significant implica-
tions for ameliorating dementia rates [2,3].
Modifiable cardiovascular risk factors have been linked
to subsequent cerebrovascular brain health, however, these
studies have generally been relatively small in terms of
sample size [4–7]. This means their estimates of association
are less likely to be reliable (e.g. influenced by outliers) [8].
The recent SPRINT trial did not show a significant effect of
SBP control on dementia rates among N¼ 9361 randomized
participants, although may have been underpowered for
that outcome [9]. The largest cross-sectional single study of
cardiovascular risk factors and brain health in the general
population [10] showed significant associations between
increased cardiovascular risk factors such as smoking his-
tory, and poorer brain structural health (N¼ 9722). That
study did not however examine concurrent cognitive abili-
ties measured during the MRI visit, as potential mediators.
The current study aims to test for associations between
higher BMI and SBP with worse cognitive abilities and
assess how much of those associations are mediated by
different brain structure measures. We will first estimate
associations between BMI and SBP vs. cognitive test scores
of trail making test (TMT) A/B; fluid intelligence (verbal–
numerical reasoning [11]); simple reaction time; matrix
completion and tower rearranging. Then secondly test
for BMI/SBP associations with structural brain phenotypes
which have been shown to underline worse cognitive
abilities and faster decline in ageing: brain grey matter
and white matter adjusted for head size [12,13], frontal lobe
volumes [10], white matter tract integrity indexed by frac-
tional anisotropy and mean diffusivity [14], total hippocam-
pal volume [15] and white matter hyperintensities (WMH)
volumes [16]. We will then test for mediation formally in
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terms of exposure (BMI/SBP), mediator (imaging) and
outcome (cognitive scores) in cases of statistically signifi-
cant three-way associations [17]. The principal hypothesis is
that higher BMI and SBP will correlate with worse cognitive
abilities and that these will be significantly mediated addi-
tively and independently by each of the imaging pheno-
types. We additionally supplement the cross-sectional tests
of association with causal estimates based on genetically
instrumented Mendelian randomization analyses [18].
METHODOLOGY
Study design and participants
UK Biobank is a large prospective cohort study including
502 628 participants who attended one of 22 baseline
assessment centres from 2006 to 2010 where they com-
pleted a series of physical, sociodemographic and medical
assessments [19]. In 2014, MRI scanning of a subgroup of
100 000 participants began, and this is ongoing. As of June
2019, MRI data were available on 29 772 participants who
attended three clinics using identical protocols (71% Chea-
dle, 24% Newcastle and 5% Reading).
Ethical approval
The secondary-data analysis study was conducted under
generic approval from the NHS National Research Ethics
Service (approval letter dated 17 June 2011, ref 11/NW/
0382). Written informed consent was obtained from all
participants in the study (consent for research, by UK
Biobank) [20]. UK Biobank is an open access resource
available to verified researchers upon application (http://
www.ukbiobank.ac.uk/). Written informed consent was
obtained from all participants in the study (consent for
research, by UK Biobank).
Data availability statement
UK Biobank is an open access resource available to verified
researchers upon application (http://www.ukbiobank.
ac.uk/). Analysis syntax is available upon request.
Imaging data
We selected imaging phenotypes a priori, previously
shown to be associated with worse cognitive ability and
to decline with age: total white matter and total grey matter
volumes adjusted for skull size [12]; log WMH volume [16];
overall hippocampal volume [15]; and general factor of
fractional anisotropy (gFA), general factor of mean diffu-
sivity (gMD) [14] and general factor of frontal lobe grey
matter (gFrontal). The release of brain MRI data as of June
2019 is the Participant of the current study. All brain imaging
data used here was processed and quality checked by UK
Biobank [21,22], and we make use here of the imaging
derived phenotypes. Details on the UK Biobank imaging
acquisition and processing including white matter /grey
matter and hippocampal segmentation, and on the white
matter diffusion processing, are freely available from three
sources: the UK Biobank protocol: http://biobank.ctsu.ox.-
ac.uk/crystal/refer.cgi?id=2367 and documentation: http://
biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977 and in pro-
tocol publications [22,23] (see open-access MRI protocol,
pp.11; https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_
mri.pdf). Total white matter hyperintensity volumes were
calculated on the basis of T1 and T2 fluid-attenuated
inversion recovery, derived by UK Biobank using the Brain
Intensity Abnormality Classification Algorithm [24] with the
procedure detailed by Miller et al. [22]. White matter hyper-
intensity volumes were log-transformed here due to a
positively skewed distribution.
We constructed general factors of white matter tract
integrity using principal components analysis. These two
separate factors were gFA (eigenvalue¼ 12.2, 55% variance
explained) and gMD (eigenvalue¼ 12.6, 57% variance
explained). Left and right hippocampal volumes were
summed to create an overall value. We constructed a
general factor of frontal lobe grey matter using 16 subre-
gional volumes described in Supplementary Table 1, http://
links.lww.com/HJH/B418 (eigenvalue¼ 6.84, 43% variance
explained). Total grey matter and white matter were cor-
rected for skull size (by UK Biobank). Significant associa-
tions with WMH were subsequently corrected for total
brain volume.
Blood pressure and BMI data
SBP was assessed using digital blood pressure (BP) mon-
itors (HEM-7015IT; Omron Healthcare Inc., Kyoto, Japan).
We used the second reading because there is evidence the
first reading can overestimate BP due to white-coat syn-
drome [25]. Weight was measured, to the nearest 0.1 kg,
using the Tanita BC-418 MA body composition analyser.
Height was measured using a Seca 202 height measure. BMI
was derived from weight (kg)/[height (m)height (m)] by
UK Biobank. Participants removed their shoes and heavy
outer clothing before weight and height were measured.
We focused on BMI in the normal to obese range and
therefore, excluded 120 participants with BMI less than
18 kg/m2 and 862 with BMI more than 45 kg/m2. (Subse-
quently including these participants in the analyses made
no difference to the results.) BMI/SBP data are concurrent
with MRI/cognitive data.
Covariates
Participants self-reported their smoking history; current,
past or never. We collated past and current smokers into
‘ever’ (vs. never). Participants self-reported medication use
for dyslipidaemia, HRT, oral contraceptive or insulin. We
excluded participants for whom these data were missing
(<5%). Townsend deprivation indices were derived from
postcode of residence [26]. This provides an area-based
measure of socioeconomic deprivation derived from aggre-
gated data on car ownership, household overcrowding,
owner occupation and unemployment. Higher Townsend
scores equate to higher levels of area-based socioeconomic
deprivation. We additionally controlled for potential pop-
ulation stratification using UK Biobank-derived principal
components 1–5, and genotypic array [27]. Apolipoprotein
e4 (APOE e4) genotype presence (vs. non e4 alleles) was
derived on the basis of two single nucleotide polymor-
phisms (SNPs): rs7412 and rs429358, included due to pre-
viously reported associations with brain structural
phenotypes [28].
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Cognitive data
Five cognitive tests were administered at the MRI visit [29].
These were verbal–numerical reasoning, pairs-matching
errors six-card version (memory), simple reaction time (proc-
essing speed), TMT A/B (processing speed/executive func-
tion), digit symbol substitution (number correct; executive
function), matrix pattern completion (nonverbal reasoning;
adapted from the common ‘matrix reasoning’) and tower
rearranging (number of puzzles correct; executive function/
planning; adapted from the common ‘towers of Hanoi/Lon-
don’). Most of these tasks are computerized versions of well
validated cognitive tests [30], whereas the tests of reasoning
and reaction time are novel to UK Biobank. The MRI-specific
tests have shown good reliability and validity [11,29].
Genetic data
UK Biobank genotyping was conducted by Affymetrix using
a bespoke BiLEVE Axiom array for50000 participants and
the remaining 450000 on the Affymetrix UK Biobank
Axiom array. All genetic data were quality controlled by
UK Biobank as described by the protocol paper [27]. Further
information on the genotyping process is available (http://
www.ukbiobank.ac.uk/scientists-3/genetic-data), including
detailed technical documentation (https://biobank.ctsu.ox.
ac.uk/crystal/docs/genotyping_sample_workflow.pdf).
In terms of genetic instruments, we used 93 independent
genome-wide significant SNPs (P 5 108) for BMI [31]
and 28 for SBP [32] (rs381815 was not genotyped). We
constructed externally weighted genetic risk scores for each
participant, based on effect estimates reported in each
discovery genome-wide association study (GWAS).
Genetic quality controlling
We included polymorphisms in Hardy Weinberg equilibrium
(P> 0.001), polymorphisms missingness rate less than 0.1 and
minor allele frequency more than 0.01. We checked all risk
allele frequencies vs. respectiveoriginalGWAS frequencies, to
ensure correct orientation. There were no exclusions due to
strand ambiguity [33]. SNPs were conservatively pruned for
linkage disequilibrium using the PLINK ‘–indep 50 5 2’ and ‘–
indep-pairwise 50 50.5’ commands; therewerenoexclusions.
Statistical analysis
The cognitive outcomes were test scores of: reasoning, digit
symbol substitution, pairs-matching errors matrix comple-
tion, towers rearranging, reaction time and TMT AþB.
Reaction time, pairs-matching errors (þ1) and TMT AþB
were log-transformed due to nonnormal distributions. The
imaging outcomes were: total white matter and total grey
matter volumes adjusted for skull size; log WMH volume;
overall hippocampal volume (left and right combined); gFA,
gMDandgFrontal. Power calculationswereperformedusing
GPower 3 [34]. PLINK v1.90 (Stata Corp., College Station,
Texas, USA) was used for genetic quality controlling [35] and
Stata V.14 was used for statistical analyses. We removed
participants who reported a neurological condition as
described previously [11]; the inclusion of which could drive
type-1 errors due to skewed results. We report betas in the
form of per-SD increases in dependent variables per one-SD
increase in the independent variable.
Models
We used two models: partially and fully adjusted. The
partially adjusted model included as covariates: age, sex,
genotypic array, MRI assessment centre and five genetic
principal components. The fully-adjusted model also
included: Townsend score, ever-smoking, self-reported
medication and APOE e4 allele presence vs. absence.
Mediation
We tested for evidence of mediation in cases of three-way
exposure/mediator (MRI)/outcome (cognition) associa-
tions. This was tested formally using the PROCESS macro
with SPSS v. 25 (IBM, Armonk, New York, USA) [17].
Instrumental variable Mendelian randomization
analyses
We tested for associations between BMI and SBP allele
scores with each outcome based on conventional Mende-
lian randomization-type instrumental variable analyses
using individual-level data: two-stage least squares analysis
for continuous traits (using Stata command ‘ivregress’ [36]).
In instances of significant associations we supplemented
this with more conservative summary-statistic based Men-
delian randomization-Egger [37] method, which is more
robust to the inclusion of pleiotropic SNPs which can bias
causal estimates and increase the rate of false positives (i.e.
type 1 errors). We aligned effect alleles and UK Biobank/
discovery GWAS allele frequencies were checked for con-
sistency. For Mendelian randomization-Egger analyses spe-
cifically we matched covariates with the discovery GWAS
summary statistics: for BMI we controlled for age and sex,
and SBP univariately; this made no difference to the results
in any case (vs. fully adjusted SNP-outcome effect sizes).
RESULTS
Descriptives
MRI data were available on 29 680 participants. We
excluded participants with non-white British ancestry,
self-report vs. genetic sex mismatch, putative sex chromo-
somal aneuploidy, excess heterozygosity and missingness
rate more than 0.1. We accounted for relatedness between
participants by removing one random participant in cases
where two individuals were 1st cousins or closer. This left
n¼ 29 200 participants. We removed participants with a
self-reported neurological condition at MRI; leaving a final
study population of N¼ 28 412 participants.
The mean post-exclusions age at baseline was 63.7 years
(SD¼ 7.49), and 12 386 (48%) participants were male. The
mean BMI was 26.58 (SD¼ 4.29; range 18–45), and the
mean SBP was 136.52 (SD¼ 18.69; range 75–237). A power
calculation showed that, based on a one-group b slope of
0.05 where each predictor had an SD¼ 1, 95% power to
detect an effect would be achieved with 4320 participants,
suggesting the study was well powered. There were signif-
icant associations between measured and genetic risk
score-estimated SBP [(standardized) b¼ 0.08, P< 0.001,
r2¼ 0.01], and BMI (b¼ 0.11, P< 0.001, r2¼ 0.02). Versus
an arbitrary dependent variable of log reaction time, unad-
justed first-stage regression F values did not suggest weak
BMI, SBP and cognition
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instrumentation (SBP F¼ 311.59, P< 0.001; BMI F¼ 149.65,
P< 0.001).
Cognitive function
There were statistically significant associations between
BMI (measured at MRI visit) with poorer log reaction time,
reasoning, matrix completion and digit symbol substitution
scores (Table 1). Higher BMI associated with better pairs-
matching performance. In terms of SBP, there were asso-
ciations between higher observed values with poorer rea-
soning and Matrix completion. These associations were
significant in fully-adjusted models and survived correction
for multiple testing with false discovery rate (FDR) [38],
although effect sizes were small: varying from 0.02 to 0.06
SDs difference in cognitive scores, per SD of SBP
(18.69 mmHg) and BMI (4.29 unit). A negative b is reflective
of better performance on reaction time (faster responses)
and pairs-matching (fewer errors), whereas for other tests
negative betas are worse.
Brain imaging
As shown in Table 2, there were significant associations
between measured BMI and smaller total grey matter vol-
ume, and larger WMH volume. Higher BMI was associated
TABLE 1. SBP, BMI and cognitive abilities: observational estimates
Partially adjusted 95% CIs Fully adjusted 95% CIs
Standardized b Lower Upper P Standardized b Lower Upper P
Log reaction time
BMI 0.024 0.013 0.036 <0.001 0.025 0.013 0.038 <0.001
SBP –0.007 –0.021 0.006 0.287 –0.012 –0.026 0.003 0.127
Reasoning
BMI –0.058 –0.070 –0.046 <0.001 –0.053 –0.066 –0.040 <0.001
SBP –0.035 –0.050 –0.021 <0.001 –0.034 –0.049 –0.018 <0.001
Matrix completion
BMI –0.052 –0.067 –0.036 <0.001 –0.048 –0.064 –0.032 <0.001
SBP –0.025 –0.044 –0.007 0.007 –0.024 –0.043 –0.004 0.020
Digit symbol
BMI –0.067 –0.082 –0.053 <0.001 –0.065 –0.080 –0.050 <0.001
SBP –0.013 –0.030 0.005 0.149 0.001 –0.018 0.019 0.952
Tower rearranging
BMI 0.011 –0.005 0.026 0.185 0.007 –0.010 0.024 0.423
SBP –0.017 –0.036 0.002 0.079 –0.017 –0.037 0.004 0.107
Pairs matching (errors)
BMI –0.030 –0.042 –0.018 <0.001 –0.032 –0.045 –0.019 <0.001
SBP –0.009 –0.023 0.006 0.241 –0.008 –0.024 0.007 0.297
The partially-adjusted model: age, sex, genotypic array, assessment centre and five genetic principal components. Fully-adjusted model: additionally corrected for self-reported
medication, ever-smoking, Townsend deprivation index and APOE e4 allele presence. Betas reflect increases per SD of the dependent variable, per increase in the independent variable.
Negative scores for better for reaction time; positive are better for the rest. CI, confidence interval.
TABLE 2. SBP, BMI and brain structural phenotypes: observational estimates
Partially adjusted 95% CIs Fully adjusted 95% CIs
Standardized b Lower Upper P Standardized b Lower Upper P
Grey matter volume
BMI –0.091 –0.102 –0.079 <0.001 –0.091 –0.104 –0.079 <0.001
SBP –0.020 –0.034 –0.007 0.003 –0.022 –0.037 –0.008 0.003
White matter volume
BMI 0.013 –0.002 0.028 0.084 0.008 –0.008 0.023 0.334
SBP 0.021 0.005 0.038 0.013 0.021 0.002 0.039 0.027
Total hippocampal volume
BMI –0.006 –0.020 0.009 0.437 –0.007 –0.023 0.008 0.368
SBP –0.011 –0.027 0.006 0.207 –0.005 –0.023 0.013 0.604
gFA: fractional anisotropy
BMI –0.009 –0.025 0.006 0.249 –0.006 –0.022 0.011 0.514
SBP –0.065 –0.083 –0.047 <0.001 –0.061 –0.081 –0.041 <0.001
gMD: mean diffusivity
BMI –0.022 –0.038 –0.007 0.004 –0.020 –0.036 –0.003 0.018
SBP 0.092 0.074 0.110 <0.001 0.091 0.072 0.110 <0.001
White matter hyperintensity volume
BMI 0.119 0.106 0.133 <0.001 0.115 0.101 0.130 <0.001
SBP 0.129 0.113 0.144 <0.001 0.125 0.108 0.142 <0.001
gFrontal
BMI 0.008 –0.004 0.021 0.199 0.009 –0.005 0.023 0.205
SBP –0.027 –0.041 –0.011 0.001 –0.025 –0.041 –0.008 0.003
The partially-adjusted model: age, sex, genotypic array, assessment centre and five genetic principal components. Fully-adjusted model: additionally corrected for self-reported
medication, ever-smoking, Townsend deprivation index and APOE e4 allele presence. Betas reflect increases per SD of the dependent variable, per increase in the independent variable.
White and grey matter adjusted for head size. CI, confidence interval; gFA, general factor of fractional anisotropy; gFrontal, general factor of frontal lobe volumes; gMD, general factor
of mean diffusivity.
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with better (i.e. lower) gMD. SBP was associated with
poorer total white matter volume, gFA; gMD, gFrontal
and WMH volume. The effect sizes were again small,
around 0.1 SDs difference in brain phenotype values, per
SD of BMI/SBP. In sensitivity analyses, the WMH associa-
tions were unaffected when adjusted for total brain volume.
Significant associations all survived correction for multiple
testing on the basis of FDR. (A positive b is worse for WMH
volume and gMD, whereas for other values negative betas
are worse.)
Mediation
We tested whether imaging measures significantly medi-
ated the associations between BMI and SBP and cognitive
scores, using cases of three-way exposure/mediator/out-
come associations. Supplementary Table 3, http://
links.lww.com/HJH/B418 shows most of the imaging and
cognitive phenotypes were inter-correlated at nominal P
less than 0.05 based on unadjusted univariate Pearson
correlations. We used the PROCESS macro Model 4 in SPSS,
hypothesising multiple mediators which can be orthogonal.
The results of the mediation analyses are shown in
Supplementary Table 4, http://links.lww.com/HJH/B418.
For BMI, there was evidence that the association between
BMI and digit symbol scores were significantly mediated by
grey matter, gMD and WMH volume overall [overall indirect
estimate¼0.007, 95% confidence interval (CI)¼0.012 to
0.001], where the association attenuated from b¼0.044
(95% CI¼0.069 to 0.011, P¼ 0.001) to b¼0.037 (95%
CI¼0.062 to 0.011, P¼ 0.005), around 19% mediated,
mostly via WMH. For SBP the association with reasoning
scores was mediated by grey matter, gFA, gMD, gFrontal and
Grey matter
Digit symbol 
substitution
Body mass index
–0.090*** –0.059***
–0.037; adjusted*
(–0.044; unadjusted**)
gMD
WMH volume
–0.019*
0.110 ***
–0.010***
–0.041***
gFA
Verbal numeric 
reasoning
Systolic blood 
pressure
–0.063*** 0.018
–0.023; adjusted*
(–0.18; unadjusted**)
gMD
Grey matter
0.082***
–0.020*
–0.009
–0.060***
WMH volume
0.135*** –0.033***
gFrontal
–0.027**
0.179 ***
FIGURE 1 Three-way associations between SBP, BMI and cognitive abilities via brain structure phenotypes. Standardized b coefficients. gFA, general factor of fractional
anisotropy; gFrontal, general factor of frontal lobe volumes; gMD, general factor of mean diffusivity; WMH, white matter hyperintensities. P<0.05 P<0.01
P<0.001.
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WMH (overall indirect estimate¼0.010, 95% CI¼0.015
to 0.006), where the association attenuated from
b¼0.028 (95% CI¼0.049 to 0.007, P¼ 0.009) to
b¼0.18 (95% CI¼0.044 to 0.002, P¼ 0.035), around
36% mediation mostly via gFrontal. These are shown in Fig. 1
(note that some mediator/outcome associations were now
NS in the context of multivariate list-wise regressions).
Genetically instrumented analyses
There were no statistically significant associations between
genetically-instrumented BMI or SBP vs. cognitive scores
(Supplementary Table 5, http://links.lww.com/HJH/B418).
In terms of brain structure, there were associations between
BMI and lower grey matter volume (b¼0.200; 95%
CI¼0.320 to 0.081; P¼ 0.001) and between SBP and
worse gFA (b¼0.362, 95% CI¼0.651 to 0.073;
P¼ 0.014) (Supplementary Table 6, http://links.lww.com/
HJH/B418). Using the more conservative Mendelian random-
ization-Egger estimates, these attenuated for BMI vs. grey
matter (b¼0.164, 95% CI¼0.358–0.031, P¼ 0.099) and
SBP vs. gFA (b¼0.005, 95% CI¼0.033–0.023, P¼ 0.703).
Sensitivity analysis
We additionally generated multivariate observational esti-
mates of association between BMI and SBP in the same
model. These results correspond to the associations
reported in the earlier observational (nongenetic) analyses
in terms of b/P value and are shown in Supplementary
Table 7, http://links.lww.com/HJH/B418.
DISCUSSION
Overview
There is a lack of data in terms of single-protocol imaging
studies with relatively large sample sizes and detailed infor-
mation on potential confounders. UK Biobank, with more
than 20000participants from the general population, is a large
step forward. This study linked differences in common office-
based assessments, easilymeasured at home – BMIand SBP –
to cognitive and structural brain phenotypes. We found
associations between BMI and SBP with poorer average
values on cognitive tests related to memory, information
processing speed, reasoning and executive function. These
abilities are important for good quality of life for example
driving and/or taking medications [39]. In terms of brain
structure, BMI was associated with lower total grey matter
and higher average WMH volume, which is potentially indic-
ativeofpoorer cerebrovascularhealth [16]. SBPwasassociated
with smaller grey matter, white matter and frontal lobe vol-
umes, poorer white matter tract integrity and higher WMH
volumes.Mediationanalysis suggestedone-fifth andone-third
of the respective linksbetweenBMIanddigit symbol tests, and
SBP with verbal–numerical reasoning, were mediated by the
aforementioned structural phenotypes, particularly a general
factor reflecting frontal lobe volumes.
Implications
Previous studies have shown that cardiovascular risk factors
are associated with poorer cognitive test scores [40], but this
study is relatively rare in showing structural imaging
phenotypes which mediate a significant fraction of the
association in a relatively large sample of middle-aged-
to-older adults with detailed confounder data. The results
are in-line with literature supporting significant frontal lobe
and cerebrovascular underpinnings to executive function
and information processing speed [41,42]. Our findings
were robustly corrected for lifestyle, demographic and
genetic factors: age, sex, smoking history, dementia risk
genotype APOE e4 [28], relevant medications and depriva-
tion. These results support the idea that cognitive decline
and brain ageing can to some extent be ameliorated by
preservation of physical health. There were instances
where BMI was associated with ‘better’ memory and white
matter integrity mean diffusivity (vs. its generally negative
associations with other brain phenotypes); highlighting the
complexity of the possible relationship between cross-
sectional adiposity vs. brain health.
Limitations
The study did not explore an exhaustive list of structural
imaging phenotypes, of which UK Biobank has now
derived several hundred. Other studies have identified
structural phenotypes which underlie substantial amounts
of general cognitive function [12], whereas we focused on a
priori known substrates of cognitive abilities. There is
evidence that vascular risk factors have different effects
on specific brain structural phenotypes for example SBP
appears to have more influence on periventricular vs. deep
WMH whereas we examined total values [43]. The specific
location of WMH may relate to different outcomes [43,44].
Providing further evidence of the involvement of SBP in
increased WMH is a strength of this study, however, the
exact pathways contributing this are still unclear [16]. It is
possible that people with MRI-related contraindications, for
example pacemakers are underrepresented here.
As most UK Biobank participants are of white European
ancestry (90%) and we focused on those participants for
purposes of homogeneity, this study does not evaluate
whether increased BMI/SBP are associated with equivalent
differences across ethnicities. This study was cross-sec-
tional, which prohibits establishment of a temporal rela-
tionship. Mendelian randomization-based causal estimates
supported a causal effect of BMI on grey matter (adjusted
for skull size) where observational associations did not and
supported a causal effect of SBP on gFA; the former
suggests some reverse causality (i.e. that cross-sectional
correlations underestimate an effect). The grey matter
association could reflect collider bias [45] in that it is relative
to skull size, and therefore, a measure of current brain size
relative to lifetime maximal (i.e. decline) [46]. Note that both
associations were null when using more conservative Egger
estimates. This could reflect SNP pleiotropy whereby the
BMI/SBP SNPs are associated with the outcomes due to
processes other than BMI/SBP specifically (pleiotropy),
insufficient statistical power or nonlinear associations [37].
Note that the mediation statistics were based on obser-
vational associations; we cannot state for certain that the
stated proportions of mediation necessarily reflect the
extent of a causal, mechanistic relationship: merely that
certain amounts variance in cross-sectional correlations
Ferguson et al.
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between BMI/SBP can be explained by certain brain
imaging metrics.
In conclusion, we showed that two commonly-assessed
cardiovascular risk factors were associated with worse cog-
nitive abilities like reasoning, information processing and
executive function and that a substantial amount of those
associations were cross-sectionally mediated by relatively
specific brain imaging metrics. This encourages the promo-
tion of healthy BMI and BP in the general population with
regards to the preservation of cognitive health in ageing.
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